Companies: 11,115     total market cap: โ‚น14477.567 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚ฌEUR๐Ÿ‡ช๐Ÿ‡บยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Novavax
NVAX
#5713
Rank
โ‚น127.77 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ United States
Country
โ‚น777.02
Share price
2.47%
Change (1 day)
25.51%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories

Novavax (NVAX) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : โ‚น114.30 Billion

According to Novavax's latest financial reports the company's total liabilities are โ‚น114.30 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Novavax - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31โ‚น117.08 B-37.52%
2024-12-31โ‚น187.38 B-10.48%
2023-12-31โ‚น209.32 B-12.55%
2022-12-31โ‚น239.37 B9.82%
2021-12-31โ‚น217.96 B211.99%
2020-12-31โ‚น69.86 B172.91%
2019-12-31โ‚น25.59 B-2.61%
2018-12-31โ‚น26.28 B1.84%
2017-12-31โ‚น25.81 B-5.01%
2016-12-31โ‚น27.17 B337.91%
2015-12-31โ‚น6.20 B111.07%
2014-12-31โ‚น2.93 B49.21%
2013-12-31โ‚น1.97 B62.79%
2012-12-31โ‚น1.21 B79.77%
2011-12-31โ‚น0.67 B-4.87%
2010-12-31โ‚น0.70 B-2.56%
2009-12-31โ‚น0.72 B-51.47%
2008-12-31โ‚น1.49 B35.1%
2007-12-31โ‚น1.10 B-10.28%
2006-12-31โ‚น1.23 B-21%
2005-12-31โ‚น1.56 B-19.29%
2004-12-31โ‚น1.93 B-11.79%
2003-12-31โ‚น2.19 B-7.39%
2002-12-31โ‚น2.37 B23.99%
2001-12-31โ‚น1.91 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Novartis
NVS
โ‚น7.659 T 6,601.21%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น11.278 T 9,767.16%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น6.411 T 5,509.05%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น5.791 T 4,966.56%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
โ‚น161.06 B 40.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚น5.29 B-95.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
โ‚น39.87 B-65.11%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
โ‚น0.10 B-99.91%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
โ‚น98.04 B-14.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น76.72 B-32.88%๐Ÿ‡บ๐Ÿ‡ธ USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com